| Dr Nathan Beck Williams, DO | |
|
191 W Union St Ste 127, Athens, OH 45701-2732 | |
| (740) 592-7010 | |
| (740) 592-7011 |
| Full Name | Dr Nathan Beck Williams |
|---|---|
| Gender | Male |
| Speciality | Osteopathic Manipulative Medicine |
| Experience | 8 Years |
| Location | 191 W Union St Ste 127, Athens, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548623044 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 34.014991 (Ohio) | Secondary |
| 204D00000X | Neuromusculoskeletal Medicine & Omm | 34.014991 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ohiohealth O'bleness Hospital | Athens, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ohiohealth Corporation | 6305758426 | 1900 |
News Archive
Although life expectancy is constantly growing in the countries of the EU, living longer isn't always the same as living well, and knowing to what age someone will live in good health remains a different question altogether.
A team of researchers led by The University of Texas M. D. Anderson Cancer Center unveiled results today from the largest-ever collaborative study addressing the treatment of a rare pediatric brain tumor. The findings suggest a new standard protocol could improve survival nearly two-fold for pediatric patients with choroid plexus tumors, as reported at the 41st Annual Meeting of the International Society of Pediatric Oncology (SIOP).
Novocure announced today that the first patient has enrolled in the EF-20 Study, an open label, pilot clinical trial of NovoTTF Therapy plus gemcitabine as first-line therapy for patients with locally advanced and metastatic pancreatic adenocarcinoma.
Concentric Medical, Inc., the global leader in acute ischemic stroke intervention, today announced that the first cases have been performed using its Trevo™ System in Europe. The Trevo System is an innovative, high performing, easy-to-use thrombus retrieval system. The main component of the Trevo System is a stentriever™, a new generation of retrieval devices which removes clots that cause stroke.
The fight against aging has received a scientific boost thanks to an innovative study done in part by a University of Alberta spin-off company-research that dispels a hard-held belief about the natural ingredient, beta glucan.
› Verified 3 days ago
| Entity Name | Ohiohealth Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578545273 PECOS PAC ID: 6305758426 Enrollment ID: O20031105000532 |
News Archive
Although life expectancy is constantly growing in the countries of the EU, living longer isn't always the same as living well, and knowing to what age someone will live in good health remains a different question altogether.
A team of researchers led by The University of Texas M. D. Anderson Cancer Center unveiled results today from the largest-ever collaborative study addressing the treatment of a rare pediatric brain tumor. The findings suggest a new standard protocol could improve survival nearly two-fold for pediatric patients with choroid plexus tumors, as reported at the 41st Annual Meeting of the International Society of Pediatric Oncology (SIOP).
Novocure announced today that the first patient has enrolled in the EF-20 Study, an open label, pilot clinical trial of NovoTTF Therapy plus gemcitabine as first-line therapy for patients with locally advanced and metastatic pancreatic adenocarcinoma.
Concentric Medical, Inc., the global leader in acute ischemic stroke intervention, today announced that the first cases have been performed using its Trevo™ System in Europe. The Trevo System is an innovative, high performing, easy-to-use thrombus retrieval system. The main component of the Trevo System is a stentriever™, a new generation of retrieval devices which removes clots that cause stroke.
The fight against aging has received a scientific boost thanks to an innovative study done in part by a University of Alberta spin-off company-research that dispels a hard-held belief about the natural ingredient, beta glucan.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nathan Beck Williams, DO Po Box 7527, Dublin, OH 43017-0727 Ph: () - | Dr Nathan Beck Williams, DO 191 W Union St Ste 127, Athens, OH 45701-2732 Ph: (740) 592-7010 |
News Archive
Although life expectancy is constantly growing in the countries of the EU, living longer isn't always the same as living well, and knowing to what age someone will live in good health remains a different question altogether.
A team of researchers led by The University of Texas M. D. Anderson Cancer Center unveiled results today from the largest-ever collaborative study addressing the treatment of a rare pediatric brain tumor. The findings suggest a new standard protocol could improve survival nearly two-fold for pediatric patients with choroid plexus tumors, as reported at the 41st Annual Meeting of the International Society of Pediatric Oncology (SIOP).
Novocure announced today that the first patient has enrolled in the EF-20 Study, an open label, pilot clinical trial of NovoTTF Therapy plus gemcitabine as first-line therapy for patients with locally advanced and metastatic pancreatic adenocarcinoma.
Concentric Medical, Inc., the global leader in acute ischemic stroke intervention, today announced that the first cases have been performed using its Trevo™ System in Europe. The Trevo System is an innovative, high performing, easy-to-use thrombus retrieval system. The main component of the Trevo System is a stentriever™, a new generation of retrieval devices which removes clots that cause stroke.
The fight against aging has received a scientific boost thanks to an innovative study done in part by a University of Alberta spin-off company-research that dispels a hard-held belief about the natural ingredient, beta glucan.
› Verified 3 days ago